APA

Bodill T., Conibear A. C., Mutorwa M. K. M., Goble J. L., Blatch G. L., Lobb K. A., Klein R. & Kaye P. T. (20140121). Exploring DOXP-reductoisomerase binding limits using phosphonated N-aryl and N-heteroarylcarboxamides as DXR inhibitors. : Bioorganic & medicinal chemistry.

Chicago

Bodill Taryn, Conibear Anne C, Mutorwa Marius K M, Goble Jessica L, Blatch Gregory L, Lobb Kevin A, Klein Rosalyn and Kaye Perry T. 20140121. Exploring DOXP-reductoisomerase binding limits using phosphonated N-aryl and N-heteroarylcarboxamides as DXR inhibitors. : Bioorganic & medicinal chemistry.

Harvard

Bodill T., Conibear A. C., Mutorwa M. K. M., Goble J. L., Blatch G. L., Lobb K. A., Klein R. and Kaye P. T. (20140121). Exploring DOXP-reductoisomerase binding limits using phosphonated N-aryl and N-heteroarylcarboxamides as DXR inhibitors. : Bioorganic & medicinal chemistry.

MLA

Bodill Taryn, Conibear Anne C, Mutorwa Marius K M, Goble Jessica L, Blatch Gregory L, Lobb Kevin A, Klein Rosalyn and Kaye Perry T. Exploring DOXP-reductoisomerase binding limits using phosphonated N-aryl and N-heteroarylcarboxamides as DXR inhibitors. : Bioorganic & medicinal chemistry. 20140121.